History of familial adult myoclonus epilepsy/benign adult familial myoclonic epilepsy around the world.


Journal

Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 05 01 2023
accepted: 06 01 2023
medline: 19 6 2023
pubmed: 29 1 2023
entrez: 28 1 2023
Statut: ppublish

Résumé

Familial adult myoclonus epilepsy/benign adult familial myoclonic epilepsy (FAME/BAFME) has emerged as a specific and recognizable epilepsy syndrome with autosomal dominant inheritance found around the world. Here, we trace the history of this syndrome. Initially, it was likely conflated with other familial myoclonus epilepsies, especially the progressive myoclonus epilepsies. As the progressive myoclonus epilepsies became better understood clinically and genetically, this group began to stand out and was first recognized as such in Japan. Subsequently, families were recognized around the world and there was debate as to whether they represented one or multiple disorders. Clarification came with the identification of pentanucleotide repeats in Japanese families, and FAME/BAFME was quickly shown to be due to pentanucleotide expansions in at least six genes. These have geographic predilections and appear to have been caused by historically ancient initial mutations. Within and between families, there is some variation in the phenotype, explained in large part by expansion size, but whether there are features specific to individual genes remains uncertain.

Identifiants

pubmed: 36707971
doi: 10.1111/epi.17519
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

S3-S8

Subventions

Organisme : National Health and Medical Research Council
ID : APP1196637

Informations de copyright

© 2023 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.

Références

Neurology. 2010 Jun 15;74(24):2000-3
pubmed: 20548044
Epilepsia. 2004 Feb;45(2):190-2
pubmed: 14738428
Mov Disord. 2005 Aug;20(8):1076-7
pubmed: 16001402
Epileptic Disord. 2016 Sep 1;18(S2):3-10
pubmed: 27621064
Brain. 2001 Dec;124(Pt 12):2459-75
pubmed: 11701600
Hum Genet. 2016 Oct;135(10):1117-25
pubmed: 27368338
No To Shinkei. 1993 Dec;45(12):1173-85
pubmed: 8123309
Brain. 2019 Nov 1;142(11):3360-3366
pubmed: 31539032
Seishin Shinkeigaku Zasshi. 1975 Jan 25;77(1):1-18
pubmed: 1173290
Nat Genet. 2001 Sep;29(1):66-9
pubmed: 11528394
Neurology. 1982 Aug;32(8):798-807
pubmed: 6808417
Ann Neurol. 1990 Jul;28(1):113-6
pubmed: 2115761
Arch Neurol. 1966 Dec;15(6):587-94
pubmed: 5925999
Eur J Hum Genet. 2021 Feb;29(2):343-348
pubmed: 32973343
J Med Genet. 1996 Jan;33(1):80-1
pubmed: 8825056
Epilepsia. 2023 Jun;64 Suppl 1:S3-S8
pubmed: 36707971
Brain. 2018 Aug 1;141(8):2280-2288
pubmed: 29939203
Nat Genet. 2018 Apr;50(4):581-590
pubmed: 29507423
Rinsho Shinkeigaku. 1984 Jan;24(1):1-8
pubmed: 6467734
Neurology. 1990 Oct;40(10):1561-5
pubmed: 2215948
Seizure. 2000 Jul;9(5):344-6
pubmed: 10933990
Eur J Hum Genet. 2020 Jul;28(7):973-978
pubmed: 32203200
Mov Disord. 2005 Jun;20(6):665-73
pubmed: 15747356
Am J Hum Genet. 1999 Sep;65(3):745-51
pubmed: 10441581
Eur J Hum Genet. 2013 Feb;21(2):225-8
pubmed: 22713812
Nat Commun. 2019 Oct 29;10(1):4920
pubmed: 31664034
Nat Genet. 1994 Jan;6(1):14-8
pubmed: 8136826
Humangenetik. 1965;1(5):437-75
pubmed: 5868699
Neurology. 2002 Mar 26;58(6):941-4
pubmed: 11914412
Neurology. 1999 Oct 12;53(6):1180-3
pubmed: 10522869
Arch Psychiatr Nervenkr (1970). 1972;215(4):362-75
pubmed: 4261385
Nat Commun. 2019 Oct 29;10(1):4919
pubmed: 31664039
Epilepsia. 2012 Feb;53(2):e33-6
pubmed: 22150818
Encephale. 1967 Jul-Aug;56(4):285-307
pubmed: 6057414
J Med Genet. 2019 Apr;56(4):265-270
pubmed: 30194086
Brain Commun. 2020 Dec 19;3(1):fcaa214
pubmed: 33501421
J Neurol. 2002 Jul;249(7):829-34
pubmed: 12140665
Brain. 1955 Sep;78(3):325-49
pubmed: 13269595
Arch Neurol. 2012 Apr;69(4):474-81
pubmed: 22491192
Curr Opin Genet Dev. 2020 Dec;65:176-185
pubmed: 32777681
Neurology. 2003 Apr 22;60(8):1381-5
pubmed: 12707452
Tremor Other Hyperkinet Mov (N Y). 2018 Jan 23;8:503
pubmed: 29416935
Seishin Shinkeigaku Zasshi. 1990;92(1):1-21
pubmed: 2112762
Nat Genet. 1994 Jan;6(1):9-13
pubmed: 8136840
N Engl J Med. 1986 Jul 31;315(5):296-305
pubmed: 3088452
Arch Neurol. 1998 Dec;55(12):1569-73
pubmed: 9865802
Brain. 1967 Sep;90(3):669-74
pubmed: 6058147

Auteurs

Samuel F Berkovic (SF)

Department of Medicine, Epilepsy Research Centre, University of Melbourne, Heidelberg, Victoria, Australia.

Pasquale Striano (P)

Pediatric Neurology and Muscular Diseases Unit, Giannina Gaslini Institute, Scientific Institute for Research and Health Care, Genoa, Italy.
Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.

Shoji Tsuji (S)

Department of Neurology, University of Tokyo Hospital, Tokyo, Japan.
Institute of Medical Genomics, International University of Health and Welfare, Chiba, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH